WALTHAM, Mass.–(BUSINESS WIRE)–Corindus Vascular Robotics, Inc. (NYSE American: CVRS), a leading developer of precision vascular robotics, announced today that Mark Toland, President and Chief Executive Officer, will present at the 13thAnnual Wells Fargo Securities Healthcare Conference. Details for the presentation include: Date September 5, 2018 Time 3:35pm EDT Location The […]
Financial
Novoheart Holdings Inc. Reports Fourth Quarter and Fiscal 2018 Financial Results
VANCOUVER, British Columbia, Aug. 22, 2018 (GLOBE NEWSWIRE) — Novoheart Holdings Inc. (“Novoheart” or the “Company”) reports financial results for the three and twelve months ended June 30, 2018. Amounts, unless specified otherwise, are expressed in Canadian dollars and are in accordance with International Financial Reporting Standards (IFRS). Q4 2018 […]
ClearFlow Awarded Chest Drainage Products Agreement with Premier
ANAHEIM, Calif.–(BUSINESS WIRE)–ClearFlow, Inc., a medical device company based in Anaheim, California, announced today that it has been awarded a group purchasing agreement for the Chest Drainage Products category with Premier. Effective July 15th 2018, the new agreement allows Premier members, at their discretion, to take advantage of special pricing and […]
Teleflex to Present at the Wells Fargo Securities 2018 Healthcare Conference
WAYNE, Pa.–(BUSINESS WIRE)–Liam Kelly, President and CEO, Teleflex Incorporated (NYSE: TFX), is scheduled to speak at the Wells Fargo Securities 2018 Healthcare Conference at the Westin Copley Place in Boston, MA, Wednesday, September 5, 2018 at 4:10 p.m. (ET). A live audio webcast of the conference presentation, along with the […]
SANUWAVE Health, Inc.’s Chairman and CEO, Kevin Richardson, Returns to Uptick Newswire’s “Stock Day” Podcast to Report on a 300% Increase in Revenue
PHOENIX, Aug. 21, 2018 (GLOBE NEWSWIRE) — (OTCQB:SNWV) — SANUWAVE Health, Inc.’s Chairman and CEO, Kevin Richardson, Returns to Uptick Newswire’s “Stock Day” Podcast to report on a 300% increase in revenue. The interview began with Jolly noting, “You know, you guys knocked it out of the park. You just […]
BioSig Appoints Johnson & Johnson Veteran Amy Scott
Santa Monica, CA, Aug. 20, 2018 (GLOBE NEWSWIRE) — BioSig Technologies, Inc. (OTCQB: BSGM), a medical device company developing a proprietary biomedical signal processing platform designed to address an unmet technology need for the $4.6 billion electrophysiology (EP) marketplace, today announced that it has partnered with Mrs. Amy Ansfield Scott in order […]
Cardurion Pharmaceuticals Appoints Jeb Keiper to Its Board of Directors
CAMBRIDGE, Mass.–(BUSINESS WIRE)–Cardurion Pharmaceuticals, a biotechnology company focused on the development of novel, next-generation therapeutics for the treatment of cardiovascular diseases, today announced the appointment of industry leader, Jeb Keiper, as an independent member of its Board of Directors. Mr. Keiper joins founder Michael Mendelsohn, M.D., Ken Novack, Ed Mascioli, […]
Endologix Appoints Jeffrey S. Brown as Chief Operations Officer
IRVINE, Calif.–(BUSINESS WIRE)–Endologix, Inc. (Nasdaq:ELGX) (“Endologix” or the “Company”), a developer and marketer of innovative treatments for aortic disorders, today announced that it has appointed Jeffrey S. Brown as the Company’s Chief Operations Officer, effective as of August 13, 2018. John Onopchenko, Chief Executive Officer of Endologix, Inc., said, “I […]
BioAxone BioSciences’ Scientific Advisory Board Member, Mark Bear, PhD, Receives $500,000 Beckman-Argyros Vision Research Award
CAMBRIDGE, Mass.–(BUSINESS WIRE)–BioAxone BioSciences, Inc., a biotechnology company focused on developing innovative drugs to treat neurotrauma and neurovascular disorders, today announced that its Scientific Advisory Board member, Dr. Mark Bear, the Picower Professor of Neuroscience at the Massachusetts Institute of Technology, received the prestigious Arnold and Mabel Beckman Foundation 2018 Beckman-Argyros […]
ROX Medical Appoints Mike MacKinnon as Chief Executive Officer
SAN CLEMENTE, Calif., Aug. 14, 2018 /PRNewswire/ — ROX Medical, Inc. (ROX), a privately held medical device company pioneering a minimally-invasive therapy for hypertension, today announced the appointment of Mike MacKinnon as its Chief Executive Officer. “Despite the many classes of drugs available to physicians to treat hypertension, millions of patients still have blood pressures […]
Recent
Popular
- No commented posts yet